Cargando…
Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML
Cytarabine has been an integral part of acute myeloid leukemia (AML) chemotherapy for over four decades. However, development of resistance and high rates of relapse is a significant impediment in successfully treating AML. We performed a genome-wide association analysis (GWAS) and identified 113 (8...
Autores principales: | Bargal, Salma A., Rafiee, Roya, Crews, Kristine R., Wu, Huiyun, Cao, Xueyuan, Rubnitz, Jeffrey E., Ribeiro, Raul C., Downing, James R., Pounds, Stanley B., Lamba, Jatinder K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201857/ https://www.ncbi.nlm.nih.gov/pubmed/30405880 http://dx.doi.org/10.18632/oncotarget.26163 |
Ejemplares similares
-
DNA Methylation Clusters and Their Relation to Cytogenetic Features in Pediatric AML
por: Lamba, Jatinder K., et al.
Publicado: (2020) -
A 6-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia
por: Elsayed, Abdelrahman H., et al.
Publicado: (2019) -
Combination of Cladribine and Cytarabine is Effective for Childhood Acute Myeloid Leukemia: Results of the St. Jude AML97 Trial
por: Rubnitz, Jeffrey E., et al.
Publicado: (2009) -
Global Proteomic Profiling of Pediatric AML: A Pilot Study
por: Nguyen, Nam H. K., et al.
Publicado: (2021) -
CC-PROMISE effectively integrates two forms of molecular data with multiple biologically related endpoints
por: Cao, Xueyuan, et al.
Publicado: (2016)